Active ingredients: Brimonidine
Alphagan 0.2% w/v (2 mg/ml) eye drops, solution.
Eye drops, solution.
Clear, greenish-yellow to light greenish-yellow solution.
One ml solution contains 2.0 mg brimonidine tartrate, equivalent to 1.3 mg of brimonidine.
Excipient(s): Contains benzalkonium chloride 0.05 mg/ml. For a full list of excipients, see section 6.1.
Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts.
Citric acid monohydrate
Hydrochloric acid (for pH-adjustment) or
Sodium hydroxide (for pH-adjustment)
White low density polyethylene dropper bottles with a 35 microlitre tip. The cap is either a conventional polystyrene screw cap or a Compliance Cap (C-Cap).
2.5 ml, 5 ml and 10 ml bottles in packs of 1, 3 or 6.
Not all pack sizes may be marketed.
Allergan Ltd, 1st Floor Marlow International, The Parkway, Marlow, Buckinghamshire SL7 1YL, UK
Date of first authorisation: 18 March 1997
Date of last renewal: 17 September 2006